Global Vaccines & Vaccination Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 325085
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Vaccines & Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Vaccines & Vaccination market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Baby Vaccine accounting for % of the Vaccines & Vaccination global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Subunit vaccines segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Vaccines & Vaccination include Abbott, AstraZeneca, Bavarian Nordic, Novartis, and Bharat Biotech, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Vaccines & Vaccination market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Subunit vaccines

Live attenuated vaccines

Conjugate vaccines

Inactivated vaccines

Recombinant vector vaccines

Toxoid vaccines

Synthetic vaccines

Dendritic cell vaccines

Market segment by Application, can be divided into

Baby Vaccine

Adult Special Vaccine

Other

Market segment by players, this report covers

Abbott

AstraZeneca

Bavarian Nordic

Novartis

Bharat Biotech

Bio-Med

CSL

Emergent BioSolutions

GSK

Johnson & Johnson

Pfizer

Merck

Sanofi

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Vaccines & Vaccination product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Vaccines & Vaccination, with revenue, gross margin and global market share of Vaccines & Vaccination from 2019 to 2022.

Chapter 3, the Vaccines & Vaccination competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Vaccines & Vaccination market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Vaccines & Vaccination research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Vaccines & Vaccination

1.2 Classification of Vaccines & Vaccination by Type

1.2.1 Overview: Global Vaccines & Vaccination Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Vaccines & Vaccination Revenue Market Share by Type in 2021

1.2.3 Subunit vaccines

1.2.4 Live attenuated vaccines

1.2.5 Conjugate vaccines

1.2.6 Inactivated vaccines

1.2.7 Recombinant vector vaccines

1.2.8 Toxoid vaccines

1.2.9 Synthetic vaccines

1.2.10 Dendritic cell vaccines

1.3 Global Vaccines & Vaccination Market by Application

1.3.1 Overview: Global Vaccines & Vaccination Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Baby Vaccine

1.3.3 Adult Special Vaccine

1.3.4 Other

1.4 Global Vaccines & Vaccination Market Size & Forecast

1.5 Global Vaccines & Vaccination Market Size and Forecast by Region

1.5.1 Global Vaccines & Vaccination Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Vaccines & Vaccination Market Size by Region, (2017-2022)

1.5.3 North America Vaccines & Vaccination Market Size and Prospect (2017-2028)

1.5.4 Europe Vaccines & Vaccination Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Vaccines & Vaccination Market Size and Prospect (2017-2028)

1.5.6 South America Vaccines & Vaccination Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Vaccines & Vaccination Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Vaccines & Vaccination Market Drivers

1.6.2 Vaccines & Vaccination Market Restraints

1.6.3 Vaccines & Vaccination Trends Analysis

2 Company Profiles

2.1 Abbott

2.1.1 Abbott Details

2.1.2 Abbott Major Business

2.1.3 Abbott Vaccines & Vaccination Product and Solutions

2.1.4 Abbott Vaccines & Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abbott Recent Developments and Future Plans

2.2 AstraZeneca

2.2.1 AstraZeneca Details

2.2.2 AstraZeneca Major Business

2.2.3 AstraZeneca Vaccines & Vaccination Product and Solutions

2.2.4 AstraZeneca Vaccines & Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 AstraZeneca Recent Developments and Future Plans

2.3 Bavarian Nordic

2.3.1 Bavarian Nordic Details

2.3.2 Bavarian Nordic Major Business

2.3.3 Bavarian Nordic Vaccines & Vaccination Product and Solutions

2.3.4 Bavarian Nordic Vaccines & Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Bavarian Nordic Recent Developments and Future Plans

2.4 Novartis

2.4.1 Novartis Details

2.4.2 Novartis Major Business

2.4.3 Novartis Vaccines & Vaccination Product and Solutions

2.4.4 Novartis Vaccines & Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Novartis Recent Developments and Future Plans

2.5 Bharat Biotech

2.5.1 Bharat Biotech Details

2.5.2 Bharat Biotech Major Business

2.5.3 Bharat Biotech Vaccines & Vaccination Product and Solutions

2.5.4 Bharat Biotech Vaccines & Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Bharat Biotech Recent Developments and Future Plans

2.6 Bio-Med

2.6.1 Bio-Med Details

2.6.2 Bio-Med Major Business

2.6.3 Bio-Med Vaccines & Vaccination Product and Solutions

2.6.4 Bio-Med Vaccines & Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Bio-Med Recent Developments and Future Plans

2.7 CSL

2.7.1 CSL Details

2.7.2 CSL Major Business

2.7.3 CSL Vaccines & Vaccination Product and Solutions

2.7.4 CSL Vaccines & Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 CSL Recent Developments and Future Plans

2.8 Emergent BioSolutions

2.8.1 Emergent BioSolutions Details

2.8.2 Emergent BioSolutions Major Business

2.8.3 Emergent BioSolutions Vaccines & Vaccination Product and Solutions

2.8.4 Emergent BioSolutions Vaccines & Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Emergent BioSolutions Recent Developments and Future Plans

2.9 GSK

2.9.1 GSK Details

2.9.2 GSK Major Business

2.9.3 GSK Vaccines & Vaccination Product and Solutions

2.9.4 GSK Vaccines & Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 GSK Recent Developments and Future Plans

2.10 Johnson & Johnson

2.10.1 Johnson & Johnson Details

2.10.2 Johnson & Johnson Major Business

2.10.3 Johnson & Johnson Vaccines & Vaccination Product and Solutions

2.10.4 Johnson & Johnson Vaccines & Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Johnson & Johnson Recent Developments and Future Plans

2.11 Pfizer

2.11.1 Pfizer Details

2.11.2 Pfizer Major Business

2.11.3 Pfizer Vaccines & Vaccination Product and Solutions

2.11.4 Pfizer Vaccines & Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Pfizer Recent Developments and Future Plans

2.12 Merck

2.12.1 Merck Details

2.12.2 Merck Major Business

2.12.3 Merck Vaccines & Vaccination Product and Solutions

2.12.4 Merck Vaccines & Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Merck Recent Developments and Future Plans

2.13 Sanofi

2.13.1 Sanofi Details

2.13.2 Sanofi Major Business

2.13.3 Sanofi Vaccines & Vaccination Product and Solutions

2.13.4 Sanofi Vaccines & Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Sanofi Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Vaccines & Vaccination Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Vaccines & Vaccination Players Market Share in 2021

3.2.2 Top 10 Vaccines & Vaccination Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Vaccines & Vaccination Players Head Office, Products and Services Provided

3.4 Vaccines & Vaccination Mergers & Acquisitions

3.5 Vaccines & Vaccination New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Vaccines & Vaccination Revenue and Market Share by Type (2017-2022)

4.2 Global Vaccines & Vaccination Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Vaccines & Vaccination Revenue Market Share by Application (2017-2022)

5.2 Global Vaccines & Vaccination Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Vaccines & Vaccination Revenue by Type (2017-2028)

6.2 North America Vaccines & Vaccination Revenue by Application (2017-2028)

6.3 North America Vaccines & Vaccination Market Size by Country

6.3.1 North America Vaccines & Vaccination Revenue by Country (2017-2028)

6.3.2 United States Vaccines & Vaccination Market Size and Forecast (2017-2028)

6.3.3 Canada Vaccines & Vaccination Market Size and Forecast (2017-2028)

6.3.4 Mexico Vaccines & Vaccination Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Vaccines & Vaccination Revenue by Type (2017-2028)

7.2 Europe Vaccines & Vaccination Revenue by Application (2017-2028)

7.3 Europe Vaccines & Vaccination Market Size by Country

7.3.1 Europe Vaccines & Vaccination Revenue by Country (2017-2028)

7.3.2 Germany Vaccines & Vaccination Market Size and Forecast (2017-2028)

7.3.3 France Vaccines & Vaccination Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Vaccines & Vaccination Market Size and Forecast (2017-2028)

7.3.5 Russia Vaccines & Vaccination Market Size and Forecast (2017-2028)

7.3.6 Italy Vaccines & Vaccination Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Vaccines & Vaccination Revenue by Type (2017-2028)

8.2 Asia-Pacific Vaccines & Vaccination Revenue by Application (2017-2028)

8.3 Asia-Pacific Vaccines & Vaccination Market Size by Region

8.3.1 Asia-Pacific Vaccines & Vaccination Revenue by Region (2017-2028)

8.3.2 China Vaccines & Vaccination Market Size and Forecast (2017-2028)

8.3.3 Japan Vaccines & Vaccination Market Size and Forecast (2017-2028)

8.3.4 South Korea Vaccines & Vaccination Market Size and Forecast (2017-2028)

8.3.5 India Vaccines & Vaccination Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Vaccines & Vaccination Market Size and Forecast (2017-2028)

8.3.7 Australia Vaccines & Vaccination Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Vaccines & Vaccination Revenue by Type (2017-2028)

9.2 South America Vaccines & Vaccination Revenue by Application (2017-2028)

9.3 South America Vaccines & Vaccination Market Size by Country

9.3.1 South America Vaccines & Vaccination Revenue by Country (2017-2028)

9.3.2 Brazil Vaccines & Vaccination Market Size and Forecast (2017-2028)

9.3.3 Argentina Vaccines & Vaccination Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Vaccines & Vaccination Revenue by Type (2017-2028)

10.2 Middle East & Africa Vaccines & Vaccination Revenue by Application (2017-2028)

10.3 Middle East & Africa Vaccines & Vaccination Market Size by Country

10.3.1 Middle East & Africa Vaccines & Vaccination Revenue by Country (2017-2028)

10.3.2 Turkey Vaccines & Vaccination Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Vaccines & Vaccination Market Size and Forecast (2017-2028)

10.3.4 UAE Vaccines & Vaccination Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Vaccines & Vaccination Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Vaccines & Vaccination Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Vaccines & Vaccination Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Vaccines & Vaccination Revenue (USD Million) by Region (2017-2022)

Table 5. Global Vaccines & Vaccination Revenue Market Share by Region (2023-2028)

Table 6. Abbott Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Major Business

Table 8. Abbott Vaccines & Vaccination Product and Solutions

Table 9. Abbott Vaccines & Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 11. AstraZeneca Major Business

Table 12. AstraZeneca Vaccines & Vaccination Product and Solutions

Table 13. AstraZeneca Vaccines & Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Bavarian Nordic Corporate Information, Head Office, and Major Competitors

Table 15. Bavarian Nordic Major Business

Table 16. Bavarian Nordic Vaccines & Vaccination Product and Solutions

Table 17. Bavarian Nordic Vaccines & Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Novartis Corporate Information, Head Office, and Major Competitors

Table 19. Novartis Major Business

Table 20. Novartis Vaccines & Vaccination Product and Solutions

Table 21. Novartis Vaccines & Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Bharat Biotech Corporate Information, Head Office, and Major Competitors

Table 23. Bharat Biotech Major Business

Table 24. Bharat Biotech Vaccines & Vaccination Product and Solutions

Table 25. Bharat Biotech Vaccines & Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Bio-Med Corporate Information, Head Office, and Major Competitors

Table 27. Bio-Med Major Business

Table 28. Bio-Med Vaccines & Vaccination Product and Solutions

Table 29. Bio-Med Vaccines & Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. CSL Corporate Information, Head Office, and Major Competitors

Table 31. CSL Major Business

Table 32. CSL Vaccines & Vaccination Product and Solutions

Table 33. CSL Vaccines & Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Emergent BioSolutions Corporate Information, Head Office, and Major Competitors

Table 35. Emergent BioSolutions Major Business

Table 36. Emergent BioSolutions Vaccines & Vaccination Product and Solutions

Table 37. Emergent BioSolutions Vaccines & Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. GSK Corporate Information, Head Office, and Major Competitors

Table 39. GSK Major Business

Table 40. GSK Vaccines & Vaccination Product and Solutions

Table 41. GSK Vaccines & Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 43. Johnson & Johnson Major Business

Table 44. Johnson & Johnson Vaccines & Vaccination Product and Solutions

Table 45. Johnson & Johnson Vaccines & Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Pfizer Corporate Information, Head Office, and Major Competitors

Table 47. Pfizer Major Business

Table 48. Pfizer Vaccines & Vaccination Product and Solutions

Table 49. Pfizer Vaccines & Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Merck Corporate Information, Head Office, and Major Competitors

Table 51. Merck Major Business

Table 52. Merck Vaccines & Vaccination Product and Solutions

Table 53. Merck Vaccines & Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Sanofi Corporate Information, Head Office, and Major Competitors

Table 55. Sanofi Major Business

Table 56. Sanofi Vaccines & Vaccination Product and Solutions

Table 57. Sanofi Vaccines & Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Global Vaccines & Vaccination Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 59. Global Vaccines & Vaccination Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 60. Breakdown of Vaccines & Vaccination by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Vaccines & Vaccination Players Head Office, Products and Services Provided

Table 62. Vaccines & Vaccination Mergers & Acquisitions in the Past Five Years

Table 63. Vaccines & Vaccination New Entrants and Expansion Plans

Table 64. Global Vaccines & Vaccination Revenue (USD Million) by Type (2017-2022)

Table 65. Global Vaccines & Vaccination Revenue Share by Type (2017-2022)

Table 66. Global Vaccines & Vaccination Revenue Forecast by Type (2023-2028)

Table 67. Global Vaccines & Vaccination Revenue by Application (2017-2022)

Table 68. Global Vaccines & Vaccination Revenue Forecast by Application (2023-2028)

Table 69. North America Vaccines & Vaccination Revenue by Type (2017-2022) & (USD Million)

Table 70. North America Vaccines & Vaccination Revenue by Type (2023-2028) & (USD Million)

Table 71. North America Vaccines & Vaccination Revenue by Application (2017-2022) & (USD Million)

Table 72. North America Vaccines & Vaccination Revenue by Application (2023-2028) & (USD Million)

Table 73. North America Vaccines & Vaccination Revenue by Country (2017-2022) & (USD Million)

Table 74. North America Vaccines & Vaccination Revenue by Country (2023-2028) & (USD Million)

Table 75. Europe Vaccines & Vaccination Revenue by Type (2017-2022) & (USD Million)

Table 76. Europe Vaccines & Vaccination Revenue by Type (2023-2028) & (USD Million)

Table 77. Europe Vaccines & Vaccination Revenue by Application (2017-2022) & (USD Million)

Table 78. Europe Vaccines & Vaccination Revenue by Application (2023-2028) & (USD Million)

Table 79. Europe Vaccines & Vaccination Revenue by Country (2017-2022) & (USD Million)

Table 80. Europe Vaccines & Vaccination Revenue by Country (2023-2028) & (USD Million)

Table 81. Asia-Pacific Vaccines & Vaccination Revenue by Type (2017-2022) & (USD Million)

Table 82. Asia-Pacific Vaccines & Vaccination Revenue by Type (2023-2028) & (USD Million)

Table 83. Asia-Pacific Vaccines & Vaccination Revenue by Application (2017-2022) & (USD Million)

Table 84. Asia-Pacific Vaccines & Vaccination Revenue by Application (2023-2028) & (USD Million)

Table 85. Asia-Pacific Vaccines & Vaccination Revenue by Region (2017-2022) & (USD Million)

Table 86. Asia-Pacific Vaccines & Vaccination Revenue by Region (2023-2028) & (USD Million)

Table 87. South America Vaccines & Vaccination Revenue by Type (2017-2022) & (USD Million)

Table 88. South America Vaccines & Vaccination Revenue by Type (2023-2028) & (USD Million)

Table 89. South America Vaccines & Vaccination Revenue by Application (2017-2022) & (USD Million)

Table 90. South America Vaccines & Vaccination Revenue by Application (2023-2028) & (USD Million)

Table 91. South America Vaccines & Vaccination Revenue by Country (2017-2022) & (USD Million)

Table 92. South America Vaccines & Vaccination Revenue by Country (2023-2028) & (USD Million)

Table 93. Middle East & Africa Vaccines & Vaccination Revenue by Type (2017-2022) & (USD Million)

Table 94. Middle East & Africa Vaccines & Vaccination Revenue by Type (2023-2028) & (USD Million)

Table 95. Middle East & Africa Vaccines & Vaccination Revenue by Application (2017-2022) & (USD Million)

Table 96. Middle East & Africa Vaccines & Vaccination Revenue by Application (2023-2028) & (USD Million)

Table 97. Middle East & Africa Vaccines & Vaccination Revenue by Country (2017-2022) & (USD Million)

Table 98. Middle East & Africa Vaccines & Vaccination Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Vaccines & Vaccination Picture

Figure 2. Global Vaccines & Vaccination Revenue Market Share by Type in 2021

Figure 3. Subunit vaccines

Figure 4. Live attenuated vaccines

Figure 5. Conjugate vaccines

Figure 6. Inactivated vaccines

Figure 7. Recombinant vector vaccines

Figure 8. Toxoid vaccines

Figure 9. Synthetic vaccines

Figure 10. Dendritic cell vaccines

Figure 11. Vaccines & Vaccination Revenue Market Share by Application in 2021

Figure 12. Baby Vaccine Picture

Figure 13. Adult Special Vaccine Picture

Figure 14. Other Picture

Figure 15. Global Vaccines & Vaccination Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 16. Global Vaccines & Vaccination Revenue and Forecast (2017-2028) & (USD Million)

Figure 17. Global Vaccines & Vaccination Revenue Market Share by Region (2017-2028)

Figure 18. Global Vaccines & Vaccination Revenue Market Share by Region in 2021

Figure 19. North America Vaccines & Vaccination Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Europe Vaccines & Vaccination Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Asia-Pacific Vaccines & Vaccination Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. South America Vaccines & Vaccination Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Middle East and Africa Vaccines & Vaccination Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. Vaccines & Vaccination Market Drivers

Figure 25. Vaccines & Vaccination Market Restraints

Figure 26. Vaccines & Vaccination Market Trends

Figure 27. Abbott Recent Developments and Future Plans

Figure 28. AstraZeneca Recent Developments and Future Plans

Figure 29. Bavarian Nordic Recent Developments and Future Plans

Figure 30. Novartis Recent Developments and Future Plans

Figure 31. Bharat Biotech Recent Developments and Future Plans

Figure 32. Bio-Med Recent Developments and Future Plans

Figure 33. CSL Recent Developments and Future Plans

Figure 34. Emergent BioSolutions Recent Developments and Future Plans

Figure 35. GSK Recent Developments and Future Plans

Figure 36. Johnson & Johnson Recent Developments and Future Plans

Figure 37. Pfizer Recent Developments and Future Plans

Figure 38. Merck Recent Developments and Future Plans

Figure 39. Sanofi Recent Developments and Future Plans

Figure 40. Global Vaccines & Vaccination Revenue Share by Players in 2021

Figure 41. Vaccines & Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 42. Global Top 3 Players Vaccines & Vaccination Revenue Market Share in 2021

Figure 43. Global Top 10 Players Vaccines & Vaccination Revenue Market Share in 2021

Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 45. Global Vaccines & Vaccination Revenue Share by Type in 2021

Figure 46. Global Vaccines & Vaccination Market Share Forecast by Type (2023-2028)

Figure 47. Global Vaccines & Vaccination Revenue Share by Application in 2021

Figure 48. Global Vaccines & Vaccination Market Share Forecast by Application (2023-2028)

Figure 49. North America Vaccines & Vaccination Sales Market Share by Type (2017-2028)

Figure 50. North America Vaccines & Vaccination Sales Market Share by Application (2017-2028)

Figure 51. North America Vaccines & Vaccination Revenue Market Share by Country (2017-2028)

Figure 52. United States Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Canada Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Mexico Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Europe Vaccines & Vaccination Sales Market Share by Type (2017-2028)

Figure 56. Europe Vaccines & Vaccination Sales Market Share by Application (2017-2028)

Figure 57. Europe Vaccines & Vaccination Revenue Market Share by Country (2017-2028)

Figure 58. Germany Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. France Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. United Kingdom Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Russia Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Italy Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Asia-Pacific Vaccines & Vaccination Sales Market Share by Type (2017-2028)

Figure 64. Asia-Pacific Vaccines & Vaccination Sales Market Share by Application (2017-2028)

Figure 65. Asia-Pacific Vaccines & Vaccination Revenue Market Share by Region (2017-2028)

Figure 66. China Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Japan Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South Korea Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. India Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Southeast Asia Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Australia Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. South America Vaccines & Vaccination Sales Market Share by Type (2017-2028)

Figure 73. South America Vaccines & Vaccination Sales Market Share by Application (2017-2028)

Figure 74. South America Vaccines & Vaccination Revenue Market Share by Country (2017-2028)

Figure 75. Brazil Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Argentina Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Middle East and Africa Vaccines & Vaccination Sales Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Vaccines & Vaccination Sales Market Share by Application (2017-2028)

Figure 79. Middle East and Africa Vaccines & Vaccination Revenue Market Share by Country (2017-2028)

Figure 80. Turkey Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Saudi Arabia Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. UAE Vaccines & Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. Methodology

Figure 84. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz